Region — US. Neutral scientific reference — not offered for sale here.
Cart · 0
Set region
Explore  /  Azelaic Acid
Research reference — not for sale

Azelaic Acid

B
lead outcome
Acne (appearance, cosmetic-strength topical)
grades vary by outcome ↓
Small molecule (non-peptide)
also called — AzA · azaleic acid (common misspelling) · nonanedioic acid · 1,7-heptanedicarboxylic acid · INCI: Azelaic Acid
skin appearance (cosmetic)hyperpigmentation appearanceeven tone / brighteningblemish appearanceredness appearance
In brief

Azelaic acid (AzA) is a dicarboxylic acid from grains and skin yeast, and one of dermatology's most versatile, best-tolerated actives — calming the look of redness, clearing the appearance of breakouts, and fading pigment through selective tyrosinase inhibition. A 2023 systematic review of 43 randomised trials found it more effective than vehicle for acne, rosacea, and melasma, with 20% azelaic comparable to 4% hydroquinone for melasma. It is graded B rather than A on honest discipline: the strongest data sits at prescription strength (15–20%), the cosmetic-accessible form is milder, results are formulation-dependent (poor solubility and penetration), and no RCTs support an anti-aging use. The prescription forms are medicines for acne and rosacea and a dermatologist's call.

Legal standing, by region
International
Lawful cosmetic (lower-strength / derivative); prescription at 15–20%

Topical azelaic acid is a lawful cosmetic ingredient at cosmetic strengths (products are often around 10%, or use gentler azelaic derivatives). Separately, 15% gel and 20% cream are regulated PRESCRIPTION medicines for acne and rosacea in many regions — stronger forms that are a dermatologist's decision and outside the scope of this cosmetic grade.

Evidence, by outcome
How we grade →

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Acne (appearance, cosmetic-strength topical)
Strongest data at prescription 15–20%; cosmetic-accessible form is milder; acne is a medical condition
King 2023 systematic review (43 RCTs) — azelaic more effective than vehicle; comparable to topical retinoids on inflammatory lesions in review-level evidence · Reduced appearance of breakouts and post-acne marks
B
Rosacea — redness & bumps (appearance)
The prescription 15% gel holds the strongest data; rosacea is a condition for a dermatologist
King 2023 — 15% gel comparable to (or better than) metronidazole in review-level evidence · Calmer-looking redness, papules, and pustules
B
Hyperpigmentation / PIH (appearance)
Gradual; formulation-dependent; daily sun protection essential
King 2023; selective tyrosinase inhibition of overactive melanocytes, fading a spot without lightening surrounding skin · Gradual fading of dark spots and post-inflammatory marks
B
Melasma (appearance)
Strongest at 20% (prescription); melasma recurs and needs a dermatologist for stubborn cases
King 2023 + Albzea 2023 meta-analysis — 20% azelaic comparable to 4% hydroquinone and better than 2% hydroquinone; lower melasma severity index than hydroquinone across pooled trials · Visible evening of melasma-related pigmentation over weeks to months
B
Skin-aging / wrinkles
No controlled evidence supports an anti-wrinkle claim
King 2023 found no eligible RCTs for skin-aging · Not demonstrated
F
Safety & tolerability (topical)
Mild, transient tingling is common early; patch test. Pregnancy compatibility is a doctor's call to confirm, not medical clearance
Broad cosmetic and prescription use; well tolerated · Generally well tolerated; widely regarded as often compatible with pregnancy
Cosmetic claims boundary
✓ Allowed (appearance / feel)
  • for the appearance of a clearer, more even complexion
  • helps reduce the look of dark spots and blemishes
  • for calmer, less red-looking skin
  • supports a smoother-looking, more uniform tone
✕ Not allowed (medicinal)
  • treats acne
  • treats rosacea
  • treats melasma
  • cures dark spots
  • inhibits tyrosinase
  • anti-inflammatory
  • antibacterial
  • reverses aging
  • anti-wrinkle

The medicinal-sounding science stays in the reference section; product copy speaks only to appearance/feel (Reg 655/2013). Different fields, never merged.

The honest part

This entry grades the COSMETIC-accessible topical form, framed around the appearance of skin. Prescription 15% gel and 20% cream are regulated medicines for acne and rosacea — stronger, and a dermatologist's decision, not something to self-manage. There is no good evidence azelaic acid does anything for wrinkles. Persistent acne, rosacea, or melasma is best assessed by a dermatologist; melasma in particular recurs and needs strict daily sun protection. Azelaic acid is widely regarded as often compatible with pregnancy, but that is a conversation to confirm with your own doctor, not medical clearance.

Identity

a dicarboxylic acid (nonanedioic acid, a nine-carbon chain) found naturally in barley, wheat, and rye, and produced on skin by the commensal yeast Malassezia. In skincare it is a small, well-tolerated multi-use active — a single molecule with anti-pigment (tyrosinase-inhibiting), calming, and pore-clearing action. It exists as a lower-strength cosmetic ingredient (often around 10%, or as gentler azelaic derivatives) and as higher-strength prescription medicines (15% gel, 20% cream) for acne and rosacea. For the full readable explanation of what it is and how it works, see the companion guide, what is azelaic acid?

Development & history

  • A naturally occurring dicarboxylic acid, studied in dermatology for decades.
  • Established as a prescription topical for acne (20% cream) and rosacea (15% gel), with a large randomised-trial base built up across the 1980s–2010s.
  • Adopted into cosmetic skincare at lower strengths and as derivatives (such as potassium azeloyl diglycinate) for the appearance of uneven tone, blemishes, and redness.
  • Consolidated by a 2023 systematic review (King et al.) pooling 43 randomised controlled trials across acne, rosacea, and melasma.

Mechanism (as proposed)

a dicarboxylic acid with several documented actions in skin: it inhibits tyrosinase (the rate-limiting enzyme of melanin synthesis) preferentially in overactive melanocytes, so it tends to fade a dark spot without lightening the normal skin around it; it scavenges reactive oxygen species (the basis of its calming, redness-reducing use); and it is mildly antimicrobial and normalises follicular keratinisation (relevant to the appearance of breakouts). Its poor water solubility and limited skin penetration make the delivery vehicle central — which is why results are formulation-dependent rather than guaranteed by "contains azelaic."

Related reading

Sources — 3 cited
01King S, Campbell J, Rowe R, Daly ML, Moncrieff G, Maybury C. A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging. J Cosmet Dermatol. 2023;22(10):2650-2662.
02Albzea W, AlRashidi R, Alkandari D, et al. Azelaic Acid Versus Hydroquinone for Managing Patients With Melasma: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cureus. 2023;15(7):e41796.
03McKesey J, Tovar-Garza A, Pandya AG. Melasma Treatment: An Evidence-Based Review. Am J Clin Dermatol. 2020;21(2):173-225.
Review status
Not yet reviewed

A credentialed reviewer (PharmD / PhD / MD) will be named before this entry is finalised. Until then, treat it as a working draft. Last updated 2026-07-12.

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
Niacinamide (Vitamin B3)A
Small molecule (non-peptide)
Vitamin C (L-Ascorbic Acid)A
Small molecule (non-peptide)
Alpha ArbutinB
Small molecule (non-peptide)
Kojic AcidC
Small molecule (non-peptide)
Tranexamic AcidB
Small molecule (non-peptide)
Explore by goal
Skin & aesthetic
Vallydia

A neutral reference and a lawful-lane shop. Registered in Spain. Information for those who seek it — never promotion.

Region — United States
ExploreRegisterThe Register — full indexCategoriesTrust & COAHow we grade
ShopCosmetic peptidesJournal
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia SL — Registered in Spain.

Azelaic Acid — evidence, uses & status · Vallydia